Latest Articles
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment.
Endometriosis is a common gynecological condition that usually affects women during their reproductive years. The main goal of this narrative review is to understand the role of the innate and …
Published: July 1, 2025, midnight
Association between endometriosis and endometrial polyps: a systematic review and meta-analysis.
Endometriosis and endometrial polyps are oestrogen-dependent conditions that frequently co-occur, yet their combined prevalence remains unclear. This study synthesized data on the prevalence of endometrial polyps in women with endometriosis …
Published: June 22, 2025, midnight
Aspira Loses $10M ARPA-H Contract but Vows to Continue Revolutionary Endometriosis Test Development - Stock Titan
Aspira Loses $10M ARPA-H Contract but Vows to Continue Revolutionary Endometriosis Test Development Stock Titan
Published: June 11, 2025, 12:30 p.m.
Development of a two-layer 3D equine endometrial tissue model using genipin-crosslinked collagen scaffolds and 3D printing - Nature
Development of a two-layer 3D equine endometrial tissue model using genipin-crosslinked collagen scaffolds and 3D printing Nature
Published: June 5, 2025, 10:08 a.m.
Sentosa Development Corporation And Mount Faber Leisure Group Celebrate - Business Post Nigeria
Sentosa Development Corporation And Mount Faber Leisure Group Celebrate Business Post Nigeria
Published: June 5, 2025, 2:29 a.m.
Link copied to clipboard!